Powered by OpenAIRE graph
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Leukemiaarrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
Leukemia
Article
Data sources: UnpayWall
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Leukemia
Article . 2012 . Peer-reviewed
License: Springer TDM
Data sources: Crossref
Leukemia
Article . 2013
versions View all 3 versions

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations

Authors: Perugini, M.; Iarossi, D.; Kok, C.; Cummings, N.; Diakiw, S.; Brown, A.; Danner, S.; +5 Authors

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations

Abstract

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH 1/2 and DNMT3A mutations

Keywords

Myeloid, Adult, Male, Adolescent, Cell Cycle Proteins, Acute, nuclear proteins, DNA Methyltransferase 3A, Young Adult, male, middle aged, 80 and over, Humans, DNA (Cytosine-5-)-Methyltransferases, Genetic Testing, humans, Aged, Aged, 80 and over, Leukemia, DNA methylation, adult, leukemia, DNA (Cytosine-5-)-methyltransferase, acute, Nuclear Proteins, DNA Methylation, Middle Aged, Isocitrate Dehydrogenase, aged 80 and over, aged, Leukemia, Myeloid, Acute, female, adolescent, Mutation, young adult, isocitrate dehydrogenase, Female, mutation, myeloid, genetic, cell cycle proteins

  • BIP!
    Impact byBIP!
    citations
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    25
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Top 10%
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Top 10%
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Top 10%
Powered by OpenAIRE graph
citations
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
25
Top 10%
Top 10%
Top 10%
bronze